The efficacy and safety of the new GLP-1 medicines continues to garner interest and will be discussed #ADA2024 Here is an updated safety-focused summary of the field and where it might be headed @DiabetesCareADA #T2D #obesity pic.twitter.com/rtEQYtHQG0 Daniel J Drucker (@DanielJDrucker) June 6, 2024 Investigational GLP-1 medicines in the clinic Late-stage investigational GLP-1 medicines for type 2 diabetes and obesity include new molecules like retatrutide and orforglipron, showing potential differentiation from semaglutide and tirzepatide through better tolerability, greater weight loss, Hb A 1c reduction, and targeted outcomes
Many times, creams and serums work only on the surface, while the real issue lies deepercaused by factors like pollution, stress, poor diet, and sun exposure
I believe we touched upon osteoarthritis, we touched upon sleep apnea, and one of the reasons that patients immediately may feel less tired is by improving their sleep apnea
Potential applications include: Ready-to-drink nutrition beverages Yogurts and fermented dairy products High-protein snack bars Better-for-you desserts Breakfast products Functional snacks Looking Beyond the GLP-1 Trend Looking Beyond the GLP-1 Trend Although much of todays conversation focuses on GLP-1 medications, the broader shift extends beyond pharmaceuticals
The median survival for the remaining indolent type is greater than 15 years
How Many Weight Loss Injections Do I Need to See Amazing Results
